Floatz logo

Zeprumetostat

Physical Activity

University of South CarolinaSmall moleculePhase 1/2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Physical Activity cohort.

Asset / SponsorPhaseRating
Genotropin
Amsterdam UMC, location VUmc
Phase 4BB
Fuzuloparib
University of South Carolina
Phase 1/2CCC
METAMIZOLE
Esbjerg Hospital - University Hospital of Southern Denmark
N/AD
Plavix
Penn State University
N/AD
DEXKETOPROFEN
Esbjerg Hospital - University Hospital of Southern Denmark
N/AD

View all 11 →

Same molecule, other indications

Zeprumetostat is also rated in:

Chronic Postsurgical PainDormant
B
Indicative ·
60 / 100
View asset →
Obese Patients With Prostate Cancer DiseaseDormant
B
Indicative ·
60 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →